Drugmaker Pfizer and its German partner BioNTech on Wednesday revealed they would be submitting their coronavirus vaccine candidate for regulatory approval “within days,” after their final analysis revealed the treatment was 95% with no major side effects.
from New York Daily News https://ift.tt/3lLRUtI
No comments:
Post a Comment